ACAD EPS Estimates
ACADIA Pharmaceuticals Inc.
$19.78
+$0.20(+1.02%)
53
Overall
75
Value
18
Tech
68
Quality
Market Cap
$3.41B
Volume
1.47M
52W Range
$19.59 - $30.96
Target Price
$32.15
ACAD EPS estimates: the consensus estimate for ACADIA Pharmaceuticals Inc.'s current fiscal year is $0.64 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
ACAD EPS Estimates
- EPS estimate, current quarter
- $0.21
- EPS estimate, next quarter
- $0.25
- EPS estimate, current year
- $0.64
- EPS estimate, next year
- $0.98
- EPS growth, 3-year
- +55.10%
| Fiscal year | EPS |
|---|---|
| 2025 | $2.32 |
| 2024 | $1.37 |
| 2023 | $-0.37 |
| 2022 | $-1.34 |
| 2021 | $-1.05 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ACAD | $19.78 | +1.0% | 1.47M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get ACADIA Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW